Market Monitor chemicals United Kingdom 2019

Market Monitor

  • Verenigd Koninkrijk
  • Chemie/Farmacie

16 jul 2019

Profitability of businesses is generally high in this sector, but Brexit poses a downside risk for businesses profitability and payment behaviour.

 

2019 uk chem 1

 

  • The British chemicals and pharmaceuticals industries add about GBP 18 billion of value to the UK economy every year, and combined they are the largest exporter of manufactured goods. Chemical products account for about 4.5% of exported goods, while pharmaceutical products represent about 8% of goods exported. The pharmaceutical sector is part of a global industry in which the UK is a leading European market and producer.          
  • The chemicals and pharmaceuticals industries mainly comprise small to medium Enterprises (SMEs) and microbusinesses, while a number of major firms are headquartered in the UK. The majority of businesses are mature with a stable customer base, as high entry barriers protect the industries (regulatory requirements and required high capital expenditure).
  • Profitability of businesses is generally high in this sector and the profit margin outlook for the coming 12 months is stable. A large number of chemicals businesses rely on asset-based finance for financing. Bank financing facilities are adequate and business refinancing does not appear to be a problem.   
  • On average, payments in the British chemicals sector take between 60 days and 90 days. Payment experience has been very good over the past couple of years and the level of protracted payments is very low. The number of non-payment and insolvency cases was low in 2018 and H1 of 2019. This trend should remain unchanged in H2 of 2019. This means that the industry is bucking the overall trend in British business insolvencies, which we expect to increase 7% this year.
  • For the time being our underwriting approach to the chemicals sector remains generally positive for all major subsectors (basic chemicals, petrochemicals, and fine and specialty chemicals). The same accounts for the pharmaceuticals industry.
  • However, the potential repercussions of Brexit pose a downside risk for businesses profitability and payment behaviour in the mid-term. Both chemicals and pharmaceuticals are part of a tightly integrated EU supply chain that relies on friction-free transfer of ingredients and finished products. At the same time, the EU accounts for 60% of British chemicals and pharmaceuticals exports.
  • In case of a hard Brexit the main impact would be tariff increases, with both exports and imports susceptible to WTO tariffs. Additionally, exchange rate losses for businesses could pose a serious risk.
  • The agricultural/farming sector could be severely impacted in the event of a hard Brexit due to major changes in the subsidy system (with the expiry of EU subsidies there is the need to replace them with a national scheme). This could negatively impact the agricultural chemicals subsector.

 

 

Downloads

Disclaimer

Elke publicatie die beschikbaar is op of vanaf onze websites, zoals, maar niet beperkt tot webpagina's, rapporten, artikelen, publicaties, tips en nuttige content, blogs, infographics, video's (hierna ‘Publicatie’) wordt louter ter informatie verstrekt en is niet bedoeld als beleggingsadvies, juridisch advies of enige aanbeveling aan de lezer(s) met betrekking tot specifieke transacties, investeringen of strategieën. Lezers zijn zelf verantwoordelijk voor het nemen van commerciële en andere beslissingen omtrent de verstrekte informatie. Hoewel Atradius al het noodzakelijke heeft gedaan om te verzekeren dat de informatie in enige Publicatie verkregen is van betrouwbare bronnen, kan Atradius niet verantwoordelijk gesteld worden voor fouten of omissies, of voor de resultaten verkregen door gebruik van deze informatie. Alle informatie in enige Publicatie wordt gegeven ‘zoals ze is’, zonder garantie op volledigheid, accuraatheid, tijdsgebondenheid, of op de resultaten verkregen door gebruik van de publicatie, en zonder garantie van enige soort, uitdrukkelijk of geïmpliceerd. In geen geval zal Atradius, haar gerelateerde partners of corporaties, of de partners, agenten of werknemers hiervan verantwoordelijk gesteld kunnen worden voor enige genomen beslissing of actie die zij zouden nemen op basis van de in enige Publicatie verstrekte informatie, of voor enig verlies van kansen, winstderving, productieverlies, omzetverlies of gevolgschade, speciale of soortgelijke schade van welke aard dan ook, zelfs wanneer de lezer in kennis is gesteld van de mogelijkheid van dergelijke verliezen of schade.